Found 33 matching trials
Pharmacokinetic Study of Peginterferon Beta-1a in Japanese and Caucasian Adult Healthy Participants.
PHASE1The primary objective of this study is to characterise the pharmacokinetics...
A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis
PHASE3General Note: throughout this record, "Rebif® New Formulation" is used for ...
Location
Multiple Locations
Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS)
PHASE2The primary objectives of the study are to evaluate the safety of BIIB061 v...
Location
Multiple Locations
Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY
PHASE4The primary purpose of this single center, randomized, open label study in ...
Location
New York University School of Medicine
Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers
PHASE1The purpose of this study is to characterize the pharmacokinetic (PK) profi...
Plegridy Satisfaction Study in Participants
PHASE4The primary objective of this study is to investigate whether Peg-IFN beta-...
A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MS
NAPeginterferon-beta-1a (PEG) is an approved treatment for relapsing forms of...
Long-Term Safety and Efficacy Study of Peginterferon Beta-1a
PHASE3The primary objective of this study is to evaluate the long-term safety and...
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
PHASE4The DELIVER-MS study seeks to answer the question: Does early treatment wit...
Status
Active Not Recruiting
Location
University of Colorado-Anschutz Medical Campus
Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers
PHASE1The primary outcome of the study is to evaluate the cumulative area under t...